CorpDev.Org
Daily 1-pager M&A Snapshot for Deal Makers
Big Deal
Draghi Challenges EU Merger Regulations: A Balancing Act for CEOs
Regulatory Balancing Act: Mario Draghi confronts EU merger police, advocating for more flexible regulations to boost competitiveness while maintaining oversight. Economic Growth Imperative: Draghi aims to close the EU's economic growth gap with the...
Regulatory Showdown: Wall Street Donors Demand Khan and Gensler’s Resignation
Regulatory Upheaval: Major Democratic donors on Wall Street are mounting pressure on Vice President Kamala Harris to replace top regulators Lina Khan (FTC Chair) and Gary Gensler (SEC Chair) due to their aggressive antitrust enforcement and...
Steel Merger Sparks U.S.-Japan Tensions: National Security Concerns Threaten Deal
Regulatory Hurdles: The proposed $15 billion merger between Nippon Steel and U.S. Steel faces significant regulatory scrutiny from U.S. authorities over national security and antitrust concerns, straining U.S.-Japan trade relations. Strategic...
$100 Billion M&A Surge Redefines US Shale Landscape
Shale M&A Surge: The U.S. shale sector is witnessing a historic $100 billion M&A surge in 2024, potentially exceeding last year's record of $155 billion. Diversification Trend: Investors are diversifying beyond the Permian Basin, with the Bakken,...
7-Eleven Owner Spurns Couche-Tard’s $35 Billion Takeover Bid Amid Strategic Misalignment
Blockbuster Bid Rejected: Seven & i Holdings, the parent company of 7-Eleven, is set to reject a $35 billion takeover offer from Canadian convenience store giant Alimentation Couche-Tard. Strategic Misalignment: 7-Eleven's board believes the offer...
Top Jobs Currently Hiring
Private Equity
International
Tech, Media & Telecom
Financial Services
Health & Life Sciences
Private Equity Titans HIG & CapVest Vie for UK’s Largest Pharma Wholesaler AAH
Bidding War: Private equity giants HIG and CapVest have entered a high-stakes bidding war for AAH Pharmaceuticals, the UK's largest pharmacy wholesaler. Company Profile: AAH services 14,000 pharmacies across the UK, generating £3 billion in annual...
Aspire Biopharma’s $316M SPAC Deal Boosts Biopharma Innovation
Strategic Financing: Aspire Biopharma's $316 million SPAC deal with PowerUp Acquisition Corp. exemplifies the growing trend of biotech firms leveraging SPACs for rapid capital infusion and growth acceleration. Sector Momentum: The biopharma...
EU Court Greenlights Illumina-Grail Merger: Industry Implications
Landmark Ruling: The European Court of Justice (ECJ) nullified the EU's probe into Illumina's $8 billion acquisition of Grail, a cancer diagnostics firm, ruling that the European Commission lacked jurisdiction. Regulatory Clarity: The decision...
$375M SPAC Merger Boosts Cancer Detection Innovator, CubeBio
Strategic Significance: CubeBio's $375M SPAC merger with Mountain Crest Acquisition Corp. V highlights the growing investor interest in innovative cancer detection technologies. Precision Oncology: CubeBio's focus on advanced molecular diagnostics...
Brookfield’s Grifols Bid: Strategic Move or Risky Bet?
Strategic Rationale: Brookfield's potential acquisition of Grifols, a leading biopharmaceutical company, represents a strategic move to expand its presence in the healthcare sector and diversify its investment portfolio. Sovereign Wealth Funds:...
